Literature DB >> 22026372

The role of nanomedicine in the imaging and therapy of thrombosis.

Jason R McCarthy, Farouc A Jaffer.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22026372      PMCID： PMC3332076          DOI： 10.2217/nnm.11.128

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  12 in total

1.  High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent.

Authors:  X Yu; S K Song; J Chen; M J Scott; R J Fuhrhop; C S Hall; P J Gaffney; S A Wickline; G M Lanza
Journal:  Magn Reson Med       Date:  2000-12       Impact factor: 4.668

Review 2.  Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.

Authors:  P W Armstrong; D Collen
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

3.  A novel site-targeted ultrasonic contrast agent with broad biomedical application.

Authors:  G M Lanza; K D Wallace; M J Scott; W P Cacheris; D R Abendschein; D H Christy; A M Sharkey; J G Miller; P J Gaffney; S A Wickline
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

4.  Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.

Authors:  S Flacke; S Fischer; M J Scott; R J Fuhrhop; J S Allen; M McLean; P Winter; G A Sicard; P J Gaffney; S A Wickline; G M Lanza
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

Review 5.  Thrombolysis in acute myocardial infarction.

Authors:  H V Anderson; J T Willerson
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

6.  A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.

Authors:  Jon N Marsh; Grace Hu; Michael J Scott; Huiying Zhang; Matthew J Goette; Patrick J Gaffney; Shelton D Caruthers; Samuel A Wickline; Dana Abendschein; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2011-04-20       Impact factor: 5.307

7.  Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.

Authors:  J N Marsh; A Senpan; G Hu; M J Scott; P J Gaffney; S A Wickline; G M Lanza
Journal:  Nanomedicine (Lond)       Date:  2007-08       Impact factor: 5.307

8.  Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.

Authors:  Yunn-Hwa Ma; Siao-Yun Wu; Tony Wu; Yeu-Jhy Chang; Mu-Yi Hua; Jyh-Ping Chen
Journal:  Biomaterials       Date:  2009-03-18       Impact factor: 12.479

9.  Multimodal nanoagents for the detection of intravascular thrombi.

Authors:  Jason R McCarthy; Purvish Patel; Ion Botnaru; Pouneh Haghayeghi; Ralph Weissleder; Farouc A Jaffer
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

10.  Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.

Authors:  Farouc A Jaffer; Ching-Hsuan Tung; Joanna J Wykrzykowska; Nan-Hui Ho; Aiilyan K Houng; Guy L Reed; Ralph Weissleder
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690
View more
  2 in total

Review 1.  Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.

Authors:  Tarek H Mouhieddine; Muhieddine M Itani; Amaly Nokkari; Changhong Ren; Georges Daoud; Asad Zeidan; Stefania Mondello; Firas H Kobeissy
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Multivalent viral capsids with internal cargo for fibrin imaging.

Authors:  Allie C Obermeyer; Stacy L Capehart; John B Jarman; Matthew B Francis
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.